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Abstract. Choosing appropriate hyperparameters for unsupervised cluster-
ing algorithms could be an optimal way for the study of long-standing challenges
with data, which we tackle while adapting clustering algorithms for immune
disorder diagnoses. We compare the potential ability of unsupervised cluster-
ing algorithms to detect disease flares and remission periods through analysis of
laboratory data from systemic lupus erythematosus (SLE) patients records with
different hyperparameter choices. To determine which clustering strategy is the
best one we resort to a Bayesian analysis based on the Plackett-Luce model
applied to rankings. This analysis quantifies the uncertainty in the choice of
clustering methods for a given problem.
1 Introduction
Since the early times of the introduction of mathematical methods for medical
diagnosis [7], remarkable advances have been made. Nowadays, the increasing
availability of medical data related to all sorts of illnesses is fostering the devel-
opment of machine learning techniques [2] for medical diagnosis and treatment.
While neural networks are often used for image based diagnosis [25, 16], super-
vised and unsupervised clustering techniques [22] are now widely employed to
investigate the role of genes in sickness [17, 24, 4, 20] and to study the response
to therapies [15, 6], as well as for assisted clinical diagnosis using information
from digital devices [18, 21]. Developing tools to assess the reliability of such
automatic procedures and to choose the best method for different situations and
clinical environments has become essential [18].
We consider here the applicability of unsupervised clustering techniques to
identify stages in time-dependent series of clinical data. More precisely, we
focus on the study of immune disorders, such as SLE, difficult to diagnose and
treat properly because many symptoms are non specific and change throughout
the evolution of the disease. SLE is a chronic autoimmune disease in which
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the immune system attacks healthy tissues by mistake [1]. This attack causes
inflammation and, in some cases, permanent tissue damage. Parts of the body
commonly affected include skin, joints, heart, lungs, kidneys, red bone marrow
(blood cell formation) and brain. Symptoms of lupus vary between people and
may be mild to severe, affect one area of the body or many, come and go, and
change over time. They include painful and swollen joints, fever, fatigue, chest
pain when breathing deeply, hair loss, mouth ulcers, swollen glands, a red rash
(typically on the face) and cardiac, renal o neural symptoms.
The cause of SLE is unknown. It is thought to involve genetics as well
as environmental factors. Female sex hormones, race, age between 15 and
45 and family history appear to be risk factors for SLE development. Aside,
emotional or physical stress, sunlight exposure, viral infections, certain drugs,
pregnancy, giving birth, smoking or vitamin D deficiency can trigger disease
flares. There is currently no cure for lupus. Treatments include nonsteroidal
anti-inflammatory drugs, corticosteroids, immunosuppressants, hydroxychloro-
quine, and immunomodulatory monoclonal antibodies. However, dealing with
a chronic disease makes one concerned about long-term adverse effects. Several
treatments for lupus have attracted great attention recently due to their ap-
plicability to covid-19 patients. In fact, serious covid-19 cases develop similar
hyperimmune responses [9] which damage the patient’s tissues and may cause
death.
Lupus patients go through periods of illness, called flares, and periods of
wellness, called remission. The symptoms during flares vary. It is essential to
be able to distinguish early when the patient is transitioning from remission
to flares, as well as what factors are causing it. A great deal of information is
contained in laboratory tests. Our purpose is to develop mathematical methods
to process it automatically from time series of such tests. We show here that it
could be possible to automatically detect transition days by applying clustering
techniques. Different clustering strategies may produce variable results on the
same datasets. Therefore, it is important to be able to assess which algorithms
perform better in given tests problems. We show that a Bayesian analysis
of rankings of the performance of clustering algorithms on medical datasets
provides information on the probability of each clustering algorithm being the
best.
The rest of the paper is organized as follows. Section 2 describes the datasets
under study. Sections 3, 4 and 5 apply K-means, Hierarchical clustering and
Density based spatial clustering to the selected datasets. Section 6 explains how
to construct performance rankings to estimate the probability of a particular
clustering procedure and hyperparameter choice to be the most adequate one
to identify automatically transition from remission to flares and other stages
in the patient evolution from time series of clinical data. We summarize our
conclusions in Section 7. A final Appendix details the clinical variables under
consideration.
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2 Clustering clinical data
Laboratory tests are often used to diagnose lupus, since the illness involves an
immune response by antibodies against the patients’s own body. In addition,
laboratory tests play a key role when detecting the transition to flares and
identifying the kind of health disorder that is building up and needs to be
treated. Tables 5-7 in the Appendix list some variables usually monitored. We
will work here with 28 patient records, choosing one dataset to illustrate the
outcome of the clustering procedures and all datasets for the Bayesian study of
the probability of a specific method being the best to identify illness stages in
these patient’s records.
All datasets are normalized subtracting the mean from each variable and
dividing by three times the variance. After that, we obtain normalized time
series of clinical data as represented in Figure 1. A difficulty in dealing with
time series of clinical data is that some measurements are usually missing. White
boxes mark missing data. We will eliminate from our study all variables with
more than 50% measurements missing. For the remaining variables, we fill
empty boxes with the average value of the variable over the remaining days.
Variables labeled as 17, 18, 28, 29, 30, 47, 48 in Tables 5-7 are suppressed. At the
end, our data set is formed by 29 columns (days) and 65 rows (variables). From
this set, we may also eliminate six more variables with essentially zero values.
Time measurements are not consecutive (they are not recorded in consecutive
days) but expand over months. The label attached to the days only indicates
time ordering. Visually, we can identify three groups of days. Group 1 is formed
by days 1 to 16, group 2 is formed by days 17 to 22, and group 3 is formed by
days 23 to 29. The complementary representation in Figure 2 shows how certain
variables get out out control as time advances, and later start coming back to
normal, responding to treatment. These observations provide the motivation to
look for clusters in clinical data.
Automatic clustering techniques may produce clusters even when the orig-
inal data contain no significative clusters. Hopkins criterion [11] allows us to
establish whether the dataset contains relevant clusters. Given a set D, the
Hopkins statistics is obtained as follows:
1. We extract a uniform sample (p1, . . . , pn) from D formed by n points.
2. For each point pi ∈ D, we find the closest neighbor pj and denote the
distance xi = dist(pi, pj).
3. We generate a random sample (q1, . . . , qn) with n points, which we call
Drandom from a uniform distribution keeping the same variance as the
original set D.
4. For each qi ∈ Drandom, we find its closest neighbor qj in D and denote
yi = dist(qi, qj).
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Figure 1: Heatmap of the reference time series of clinical data.
Figure 2: Bar histogram of the reference clinical data.
5. We calculate the Hopkins statistics as
H =
∑n
i=1 yi∑n
i=1 xi +
∑n
i=1 yi
.
If D was uniformly distributed, then the sums
∑n
i=1 yi and
∑n
i=1 xi would be
similar, and H would be close to 0.5. However, if there are clusters present in
D, the distances to the artificial points (
∑n
i=1 yi) would be larger than4 those
to the true points (
∑n
i=1 xi) and H would be larger than 0.5. The larger is H,
the more likely the presence of clusters in the data is.
For our dataset, H = 0.655, so that it makes sense applying clustering
techniques. An additional issue when dealing with medical data, is whether
such clusters have a medical meaning, which will be the case here.
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3 K-means clustering
K-Means [14] is one of the most widely used unsupervised clustering algorithms.
The idea is to group observations in clusters so that the total intra-cluster
variation is minimized.
3.1 Algorithm description
Given an observation xi = (xi,1, . . . , xi,M ) in a M dimensional space, a cluster
Cj of points in the same space and the cluster centroid µj , we define the intra-
cluster total variation as:
K∑
j=1
W (Cj) =
K∑
j=1
∑
xi∈Cj
d(xi,µj),
where d represents the euclidean distance
d(xi,µj) =
√√√√ M∑
`=1
(xi,` − µj,`)2.
The centroids of each cluster Cj with |Cj | observations are defined as the av-
erages of the observations in the cluster, that is, µj =
∑
xi∈Cj xi/|Cj |. The
intra-cluster total variation can be interpreted as a measure of the cluster com-
pactness. Each term W (Cj) is the intra-cluster variation for a single cluster:
W (Cj) =
∑
xi∈Cj
d(xi,µj),
where xi are the points belonging to the cluster Cj . In our case, each observation
is formed by measurements of M clinical variables a specific day.
Once the number k of clusters to be formed is specified, the K-Means algo-
rithm proceeds in the following steps:
1. We initialize the centroids µj generating generate k random points in the
M dimensional space.
2. Each observation xi is assigned to the closest centroid according to the
euclidean distance.
3. For each cluster, we update the centroid as the average of the cluster
observations.
4. We minimize the total intra-cluster variation iteratively. To do so, we
iterate the previous steps until the clusters do not change or the maximum
number of iterations is surpassed.
The main drawback of this algorithm is the need of knowing the number of
clusters beforehand. We describe some strategies to estimate it next.
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3.2 Selection of the number of clusters
Two methods can be used to estimate the number of clusters in K-Means: the
Elbow method and the Silhouette method. While the Elbow method favors
cluster compactness, the Silhoutte analysis opts for cluster separation when
selecting k.
The Elbow method is based on running K-Means for different choices of
the number of clusters. Each run stores the total intra-cluster variation. The
number of clusters N is selected in such a way that the total intra-cluster vari-
ation does not diminishes noticeably for k + 1. This can visualized graphically,
plotting the total intra-cluster variation as a function of k. When applied to
our reference clinical dataset, we find Figure 3(a), which suggests k = 3, 4, 5 as
reasonable values.
(a) (b)
Figure 3: (a) Elbow Method: Change in the total intra-cluster variation as a
function of the number of clusters k. (b) Silhouette method: Silhouette coeffi-
cient as a function of the number of clusters k.
The Silhouette analysis [13] measures cluster quality. This method deter-
mines the quality of a cluster estimating how well the point fits in the cluster.
This is done calculating the mean distance from each point to the other clusters,
the so-called Silhouette coefficient. Choosing the number of clusters maximiz-
ing the Silhouette coefficient we guarantee a sharp separation between clusters.
Figure 3(b) represents the Silhouette coefficient as a function of k for our ref-
erence dataset. The value maximizing the coefficient is k = 4, though k = 3 is
only slightly worse.
3.3 K-Means applied to a time series of clinical data
The results obtained running K-Means for k = 3 and k = 4 clusters are repre-
sented in Figures 4 and 5.
As Figure 4 shows, the algorithm is able to identify groups of days, which are
almost consecutive. The first (red) group includes days 21 to 29. The second
(green) group includes days 1 to 16, skipping day 15. Finally, the third (blue)
6
Figure 4: Clusters obtained with K-Means when k = 3.
group includes days 17 to 20, and also day 15. Notice that day 15 is an anomaly
for K-Means.
Let us see the behavior for k = 4. Again, Figure 5 shows, that the algorithm
is able to identify groups of days. The first (red) group includes days 1 to 13.
The second (green) group includes days 17 and 18. The third (blue) group
includes days 24 to 29. Finally, the fourth (magenta) group includes days 14 to
16, plus days 19-23. This time days 17-18 are an anomaly for K-Means.
As a conclusion, days 15, 17 and 18 are difficult to explain for this algorithm.
This may mean that they are days at which the patients’ condition changes.
Figure 5: Clusters obtained with K-Means when k = 4.
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4 Hierarchical clustering
Hierarchical clustering [23] is a popular strategy for unsupervised learning. We
will use here the agglomerative version of the algorithm, which works bottom
up. Each element is initially considered a cluster itself. A cluster formed by a
single element is a leaf. At each step, the two most similar clusters merge to
form a bigger one, called node. This process is repeated progressively until all
the points are combined in a big cluster, the tree.
4.1 Algorithm description
This algorithm requires a similarity measure between elements and a strategy to
merge clusters. Different distances can be selected as similarity measures. Here
we use the euclidean distance. The elements to be compared are the values of
the M variables for different days. Considering them points in a M dimensional
space, we can compute the euclidean distance between them. Regarding the
clustering strategy, we calculate the distances between all the elements and use
the ’complete’ approach. Each node’s height in the tree represents the distance
between the two subnodes merged at that node. All leaves below any node
whose height is less than a threshold C are grouped into a cluster (a singleton if
the node itself is a leaf). This process is represented in a dendrogram, a graph
representing how the clusters merge until they form the tree that contains them
all. As we move upwards the most similar clusters combine in branches that
merge later at a higher height, known as the cophenetic distance between the
clusters. The higher that height, the more different the clusters are.
Once a hierarchical tree is built, we have to check whether it is representative
of our set of data, that is, whether the heights represent the original distances
with reasonable accuracy. To do so, we calculate the correlation between the
cophenetic distance and the original distance used to check similarity between
objects, the euclidean distance in our case. If the correlation coefficients displays
a large coefficient in a linear relation, say, larger than 0.75, the tree is considered
a good representation of the dataset. Selecting a particular height to cut the
tree, we obtain different numbers of clusters.
4.2 Hierarchical clustering applied to a time series of clin-
ical data
In this section we use the hierarchical clustering to select the onset of severe
illness periods in time series of measurement of the clinical variables of lupus
patients. The dendrograms in Figure 6 and 7 show the outcome of applying
agglomerative hierarchical clustering based on the euclidean distance cut at a
different height. The resulting tree is a good representant of the data set, since
the correlation between the cophenetic distance and the euclidean distance is
0.7767 > 0.75. We select the hyperparameter, that is, the height, is such a way
that we obtain the number of clusters we considered with K-means. In the first
case, choosing a threshold height to have 3 clusters, days 15, 17, 18 are singled
8
out. In the second one, with 4 clusters, day 17 is marked as possible onset. Days
15, 17, 18 are automatically identified as days at which the patients condition
may change significantly again.
Figure 6: Dendrogram representing 3 clusters in the time sequence of clinical
variables
Figure 7: Dendrogram representing 4 clusters in the time sequence of clinical
variables
4.3 Grouping clinical variables
Both K-Means and hierarchical clustering select the same days to mark a strong
alteration in the status of a patient. We can analyze the clinical variables by a
9
combination of both.
Figure 8: Heatmap of the matrix relating the K-Means centroids for the k = 3
clusters of days and the clinical variables. We have superimposed a dendrogram
classifying the variables in groups according to their influence in the cluster
centroids.
K-Means algorithm provides a matrix describing how each variable influ-
ences the final centroids. We represent this matrix by means of a heatmap for
k = 3 clusters, see Figure 8. Then, we superimpose a dendrogram grouping
the variables by similarity. In this way, we distinguish 6 groups of variables
according to their interactions through the clusters. Considering high values
the largest positive ones, intermediate values those about 0 and small values
the largest negative ones, we observe:
• The low values of group 1 identify the first cluster, while intermediate
values are typical of the second and third clusters.
• The low values of group 2 identify the first cluster, while intermediate
values are typical of the second cluster and large values of the third cluster.
• The large values of group 3 identify the second cluster, while small values
are typical of the first and second clusters.
• The large values of group 4 identify the second cluster, while small values
are typical of the third cluster and intermediate values of the first cluster.
• The low values of group 5 identify the second cluster, while intermediate-
large values are typical of the first and third clusters.
• The large values of group 6 identify the first cluster, while intermediate-
small values are typical of the second and third clusters.
A few variables remain almost constant through the clusters and we have left
them unassigned. This shows that they have little effect on the overall clustering
results and we may as well suppress them. These relations are illustrated in
Table 4.3. Variables for which the heat map reports large positive values within
the cluster affect strongly the centroid: its coordinate in the direction of that
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variable is large. Considering variables for which the heat map reports small
values (that is, large negative values) within the cluster, the centroid varies
strongly in the opposite direction. In practice, this information would allow to
track automatically which variables play relevant roles in each cluster of days
and motivate the change.
Large Intermediate Low
Group 1 2-3 2-3 1
Group 2 3 2 1
Group 3 2 1-3 1-3
Group 4 2 1 3
Group 5 1-3 1-3 2
Group 6 1 2-3 2-3
Table 1: Relation between day clusters and clinical variable blocks.
5 Density-based spatial clustering
The Density-Based Spatial Clustering of Applications with Noise (DBSCAN)
algorithm usually allows us to detect clusters of any structure even in the pres-
ence of noise and outliers. This technique is based on the spatial density of
points, following human intuition to identify clusters. For instance, in Figure 9,
we visually spot four clusters in spite of the presence of noise due to the point
density variations.
Figure 9: Density based cluster identification in the presence of noise.
The method looks for high density regions and assigns clusters to them,
while points in less dense regions are left outside and become anomalies. This
is the main advantage of this algorithm: being able to detect outliers. Another
advantage is that methods such as K-Means and Hierarchical Clustering are
designed to find spherical or convex clusters, that is, they work well when we
must find well separated and compact clusters, which is not always the case.
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Moreover, K-Means also needs to classify all the points in one cluster forcing
the introduction of weird criteria to detect outliers.
5.1 Algorithm description
The DBSCAN algorithm is governed by two hyperparameters:
• ε: Smallest distance for two points to be considered neighbors.
• MinPts: Minimum number of points required to form a cluster.
According to them, we distinguish three types of points:
• Core Point: Any point with a number of neighbors greater than or equal
to a fixed minimun value MinPts (including itself).
• Border Point: Any neighbor of a core point with a number of neighbors
smaller than MinPts.
• Outlier: Any point which is not a core neither a border point.
Figure 10 illustrates the three types of points for a given ε and MinPts = 6.
Point x is a core point, it has at least 5 neighbors at a distance smaller than ,
a total of 6 points counting x. On the other hand, y is a border point, since the
number of neighbors is smaller than 6, but it is a neighbor of the core point x.
Finally, z is an outlier. Although it is a neighbor of y, it is not a neighbor of
any core point and it has less than 6 neighbors.
Figure 10: Cluster detection in the presence of noise by density criteria.
Before describing the algorithm in detail, we need to distinguish three con-
cepts:
• Directly reachable points: A point A is directly reachable from B when it
is a neighbor of B and B is a core point.
• Reachable points: A point A is reachable from B when we can find a set
of core points from B to A.
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• Connected point: Two points A and B are connected when there is a core
point C such that A and B are reachable from C.
A density based cluster is a group of connected points. The DBSCAN algorithm
works as follows:
1. For each point xi, we calculate the distance between xi and the remaining
points. Then, we find all the neighbors within the radius ε and mark as
core points those with a number of neighbors greater or equal to MinPts.
2. For each core point not yet assigned to a cluster, we create a new cluster.
Next, we search for all the points connected to that core point and assign
them to that cluster.
3. We repeat those steps over the remaining set of points.
4. The points not assigned to any cluster after this process are considered
outliers.
5.2 Hyperparameter tuning
Determining adequate values for ε and MinPts is a difficult task, strongly
conditioned by the structure of the dataset we are working with. In general,
there is no automatic procedure to do so. The main problems caused by a poor
choice are:
• If the value of ε is too small, there will not be enough points to form
clusters and most points risk being classified as outliers. On the other
hand, if ε is too large, most points will be classified in clusters and we will
not be able to identify the outliers.
• If MinPts is too large, too many points are required to form a cluster.
Dense regions may be classified as outliers. When it is too small, low
density regions would appear as clusters and outliers would remain unde-
tected.
These values have to be carefully tuned to detect meaningful outliers. Our
choice will be to find optimal values of ε given MinPts. We start calculating the
means of the distances to the k closest points and represent them in increasing
order. Turning points will mark thresholds for sharp changes and will provide
candidate values for ε.
5.3 DBSCAN applied to a time series of clinical data
In this section we explain how to use the clustering algorithm DBSCAN [8] to
select the onset of severe illness periods in time series of measurement of the
clinical variables of lupus patients.
We select ε fixing the hyperparamenter MinPts = 3, minimum number of
days in clusters usually observed in our previous studies. The resulting graph
13
Figure 11: Graph of ascending 3-distances for the reference dataset of medical
variables.
would be We appreciate two turning points, at ε = 3 and ε = 4. However, ε = 4
is too large and all the points form a cluster. Running the algorithm with ε = 3
and ε = 3.5 we find the following.
For MinPts = 3 and ε = 3, there are five outliers. The first one (day 15)
marks the correct onset of the sickness period, see Figure 12(a). On the other
hand, when MinPts = 3 and ε = 3.5, we find a single outlier (day 17), two
days later, see Figure 12(b). This technique confirms what we have previously
observed: the clinical variables are strongly altered between the days 15 and 17.
(a) (b)
Figure 12: (a) Clusters and outliers with DBSCAN and ε = 3. (b) Clusters and
outliers with DBSCAN and ε = 3.5.
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6 Bayesian inference for clustering performance
For the same set of data, results vary using different clustering procedures.
Thus, comparing the performance of different clustering strategies to extract
useful information from clinical datasets is an important task. In the previous
sections, we have illustrated the use of clustering strategies on a dataset to obtain
information on the phases of the illness of a patient, in particular, to characterize
the onset of deterioration and recovery periods. Next, we describe how to infer in
an automatic way which methods are more adequate for particular collections of
clinical records by combining the construction of rankings on smaller collections
of selected datasets and Bayesian analysis.
6.1 Bayesian inference for ranking analysis
The idea is to run the clustering methods to be compared on a number of
datasets for which the diagnosis is known, and then rank them according to
their performance. Finally, we analyze the results using a Plakett-Luce (PL)
Bayesian model [5, 12]. This model is well adapted to this type of problems and
differs from other approaches for continuous problems [3].
An advantage of PL models is that normalized parameters represent di-
rectly the marginal probability of an algorithm being placed in first position.
Another advantage is that is relies on a finite number of parameters, as many
as algorithms we compare. It also fulfill’s Luce’s axiom: ’The probability of an
algorithm A of being placed before algorithm B is the same independently of
the remaining algorithms’.
The PL model combines three ingredients:
1. It selects randomly the algorithm to be positioned.
2. Each algorithm has a weight wi, and the probability to select an algorithm
at each stage is the ratio between its weight and the sum of the weights
of the remaining algorithms.
3. Representing by σ = (σ1, . . . , σn) a ranking of size n, where σi = j
implies that the j-th algorithm is locates at the i-th position and by
w = (w1, . . . , wn) the vector of weights, the PL probability to select that
ranking is:
PPL(σ) =
n∏
i=1
wσi∑n
j=i wσj
.
By simplicity, we assume that the sum of weights is 1.
More precisely, the process, schematized in Figure 13, is the following:
1. Run the clustering algorithms overm datasets. Choosing a way to evaluate
the performance of the algorithms, we will have a matrix M in which
M(i, j) is the performance of algorithm j on dataset i.
15
Figure 13: Scheme for the Bayesian analysis of clustering ranking performance.
2. Assign a position in the ranking to each algorithm: the greatest the per-
formance, the higher the situation in the ranking. In this way, we obtain
a matrix R, where R(i, j) is the location in the ranking of algorithm j
applied to dataset i.
3. A given matrix R gives partial information of the likelihood of different
clustering algorithms to perform better than the rest. We quantify the
uncertainty in such conclusions using Bayes relation for conditional prob-
abilities
P (w|R) ∝ P (w) · P (R|w),
where w = (w1, ..., wn) denote the PL parameters. Since we are assuming∑n
i=1 wi = 1, they represent the probability of having a given algorithm
in the first position. We set
P (R|w) = Πσ∈RPPL(σ,w),
P (w) = Dir(w,α),
where the Dirichlet distribution models uncertainty in the weights.
4. Since the posterior distribution does not have a closed form, we sample
it using Markov Chain Monte Carlo (MCMC) methods [10]. From the
set of samples, we visualize uncertainty in the probability of a clustering
strategy being the best by means of histograms or expected values.
The Dirichlet distribution Dir(α) is a family of multivariate distributions
parametrized by a vector α of real positive numbers. It generalizes the Beta
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function. The Dirichlet distribution of order K ≥ 2 with positive parameters
α1, . . . , αK has a density function
f(x1, . . . , xK ;α1, . . . , αK) =
1
B(α)
K∏
i=1
xαi−1i
where
∑K
i=1 xi = 1 and xi ≥ 0 for i ∈ [1,K]. The normalization constant is a
multivariate Beta function expressed in terms of Gamma functions as:
B(α) =
∏K
i=1 Γ(αi)
Γ(
∑K
i=1 αi)
α = (α1, . . . , αK).
Since we lack information on the perfomance of the algorithms for general
datasets, we use a uniform distribution for the hyperparameter α, that is,
αi = α = 1, i = 1, . . . , n.
6.2 Plackett Luce method applied to time series of clinical
data
We apply our clustering techniques to identify groups of days reflecting different
stages of the evolution of the patient. We consider the clinical records of 28
patients which have been previously diagnosed. In many cases there are sickness
periods which require special medical care, starting a known specific day. This
results in a time series of measurements of clinical variables, which display a
different behavior before and after it. A way to quantify the performance of the
different algorithms of the datasets if to check how well they predict the onset
of that flares period. Therefore, we need to define an automatic criterion to
identify it based on the different clustering strategies:
• For the DBSCAN algorithm we select the first day not assigned to any
cluster, that is, the first outlier.
• For K-Means, we choose the first day which is unsequentially classified,
that is, which has no neighbors in the same cluster. When such a day is
not found, we choose the first day of the smallest cluster.
• For hierarchical clustering, we choose the smallest of the last isolated
points to merge with existing clusters. If not found, we choose the first
day within the smallest cluster.
Performance is quantified by means of the difference between the day estimated
from the clustering analysis and the known true transition day.
Let us revise the clustering analysis performed on our test dataset and apply
these criteria. The onset of an unstability period for the patient is defined by
Day 15.
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• For DBSCAN with MinPts = 3 and ε = 3, we had five outliers in Figure
12(a). The smallest corresponds to day 15. The distance is D = 0. When
k = 3 and ε = 3.5, we had one outlier in Figure 12(b), day 17. The
distance is D = 2.
• K-Means with k = 3 introduces the first temporal mismatch on day 15,
assigning this day to the third cluster (blue), instead of the second cluster
(green), see Figure 12. The distance is D = 0. When k = 4, we have a
mini-cluster with days 17 and 18. The distance is D = 2. When k = 5, the
first temporal mismatch happens for day 11, and the distance is D = 4.
• Hierchical clustering with 4 clusters, as depicted in Figure 7, singles out
day 17. Therefore the distance is D = 2. Figure 6 considers 3 clusters
instead. The smallest day in the smallest cluster is 15, thus the distance
is D = 0.
We have applied these methods to 28 different clinical datasets, quantify-
ing for each one the distance between the predicted and true transition days.
We have excluded some datasets for several reasons. On three of them all the
algorithms gave the same answer. Three more are discarded because the Hop-
kins statistics is too small to support looking for clusters. The variables just
fluctuate. Three additional datasets are too complicate to analyze since they
seem to present several periods of flares and remission, and should be divided
in smaller periods. Thus, we study the remaining 19 datasets, which present
only one transition. The results are represented in Table 2, where HC stands
for hierarchical clustering (3C with 3 clusters, 4C with 4 clusters) and KM by
K-Means.
Based on those distances, we build the ranking presented in Table 3. We as-
sign a higher position in the ranking to smaller distances. The smallest possible
distance is D = 0. Smallest distances rank first. Ties are solved assigning the
same position to tied algorithms and freeing the next positions in equal number.
Following this procedure, we obtain Table 3.
We notice that K-Means with k = 3, Hierarchical clustering with 3 clusters
and DBSCAN with ε = 3 and MinPts = 3 perform quite well. We will use
the PL method to determine the probability for each algorithm being the best,
as well as the uncertainty in our choice of algorithm. Notice that there are
repetitions in the ranking, obtaining the results represented in Table 6.2.
The results in Table 6.2 indicate that hierarchical clustering with 4 clusters
is the algorithm performing best, with a probability of 21.30%. Next, it follows
K-means with 3 clusters, with a 20.36% probability, which worsens increasing
the number of clusters. DBSCAN appears with probability 18.73%.
In spite of the narrow differences, hierarchical clustering algorithms outper-
form the rest due to two reasons. First, they adapt well to small datasets.
Second, they do not require a previous knowledge of the number of clusters,
one can infer reasonable values from the tree. DBSCAN algorithms perform
worse that expected. This algorithm is devised to look for outliers, since it does
not need to place all points in a cluster, unlike K-means. However, for many
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Distance to
transition days
KM
k=3
KM
k=4
KM
k=5
HC
3C
HC
4C
DBSCAN
MinPts=3, ε=3
D15 0 2 4 0 2 0
D4 0 1 1 0 0 0
D9 0 6 6 9 9 2
D3 2 2 2 0 0 0
D1 2 2 0 2 2 0
D1 6 10 10 0 0 0
D16 6 6 9 19 19 15
D14 0 0 11 0 0 0
D5 0 1 1 0 0 0
D9 0 5 5 3 5 5
D19 0 0 16 17 0 17
D50 41 41 41 4 0 0
D1 3 0 0 0 0 0
D23 22 22 41 0 0 21
D17 0 9 9 0 0 12
D19 14 14 14 0 7 18
D11 6 0 0 0 0 4
D3 21 14 0 19 21 0
D12 11 0 0 11 0 10
Table 2: Distances to the transition day for the different algoritms.
parameter choices we may find no outliers. Analyzing the results, we observe
that either it gives sharp predictions or it produces the worst predictions. This
may reflect a difficulty in tuning the hyperparameters in these algorithms, we
just used the values selected for the reference case. On the other hand, K-Means
is a classical algorithm that performs poorly in outlier detection. This is due to
the need of placing all points in a cluster, the difficulty to handle non convex
clusters, and the requirement of a priori information on the number of clusters.
Let us finally point out that the results vary with the definitions of transition
days and distances for the different algorithms. If we adopt a different definition
for hierarchical clustering techniques exploiting the cophenetic distances, then
it outperforms the rest. Here we chose the simplest definitions to illustrate the
procedure.
7 Conclusions
Extracting information from real clinical data in an automatic fashion faces a
number of challenges, such as the unavailability of large enough amounts of data
and incompleteness of the records, for instance. For each patient undergoing
the same illness, slightly different variables may have been monitored and time
intervals between tests vary largely. Unsupervised clustering methods provide
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N
KM
k=3
KM
k=4
KM
k=5
HC
3C
HC
4C
DBSCAN
MinPts=3,ε=3
1 1 4 6 1 4 1
2 1 5 5 1 1 1
3 1 3 3 5 5 2
5 4 4 4 1 1 1
6 3 3 1 3 3 1
7 4 5 5 1 1 1
8 1 1 3 5 5 4
9 1 1 6 1 1 1
10 1 5 5 1 1 1
11 1 3 3 2 3 3
12 1 1 4 5 1 5
14 4 4 4 3 1 1
15 6 1 1 1 1 1
18 4 4 6 1 1 3
23 1 4 4 1 1 6
24 3 3 3 1 2 6
27 6 1 1 1 1 5
28 5 3 1 4 5 1
29 5 1 1 5 1 4
Table 3: Rankings generated from the distances to the transition day in Table
2.
KM
k=3
KM
k=4
KM
k=5
HC
3C
HC
4C
DBSCAN
MinPts=3, ε=3
0,148702 0,137208 0,11005 0,20365 0,213026 0,187354
Table 4: Results obtained applying the Plackett Luce method to the ranking in
Table 3.
a tool to obtain basic information. We have compared the potential of DB-
SCAN, K-means and hierarchical clustering techniques to detect the presence
of transitions from remission to flares in lupus patients using the time records
of standard laboratory tests. When faced with large numbers of data sets, one
must figure out which clustering strategy is likely to be the best one for most of
them. We show that a Bayesian analysis based on the Plackett-Luce model ap-
plied to performance rankings of clustering algorithms on a collection of model
clinical datasets may identify the best methods with quantified uncertainty.
Ideally, one would like to go further and identify patterns representing a type
of flare in the data, to which new datasets could be compared. In that way, we
might be able to diagnose automatically what particular manifestation of lupus
we need to treat. This is a challenge due to the fact that available hospital
records usually display different variable collections measured over irregular time
20
periods, reacting often to emergencies.
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Appendix: Clinical variables.
We list here the clinical variables involved in the test datasets under study,
see Tables 5 and 7. The labels refer to the variables involved in the refer-
ence dataset used through the text to exemplify the performance of clustering
algorithms. The ranking for the Bayesian analysis uses additional datasets con-
taining measurements of most of these variables. As it is to be expected from
patients’ records stored in hospitals, the datasets do not always record all the
variables, and the days at which measurements are taken vary with the patient.
Blood Test - Variable Label Urine Test - Variable Label
Glucose 1 pH 33
Urea 2 Density 34
Creatinine 3 Proteins (strip) 35
Glomerular Filtration 4 Glucose 36
Uric Acid 5 Ketone bodies 37
Cholesterol 6 Bilirubin 38
Cholesterol HDL 7 Urobilinogen 39
Cholesterol LDL 8 Nitrites 40
Triglyceride 9 Leukocytes 41
Total Proteins 10 Red blood cell 42
Albumin 11 Turbidity 43
Calcium 12 Sediment Comment
Phosphorus 13 Leukocytes per field 44
Sodium 14 G6PD quantification
Potassium 15 Red blood cell shadow 45
Chloride 16 Hyaline cylinders
Bicarbonate 17 Cell Peeling
Iron 18 Creatinine 46
Total Bilirubin 19 Proteins
Creatine Kinase (CK) Albumin 47
Lactate dehydrogenase (LDH) 20 Microalbumin/Creat. Ratio 48
Alanine Aminotransferase (ALTGPT) 21 Haptoglobin
Aspartate Aminotransf. (ASTGOT) 22
Phosfatase Alkaline 23
Gamma Glutamyltransferase (GGT) 24
Vitamin B12 25
Folic Acid 26
C-Reactive Protein 27
Ferritin 28
Transferrin 29
Transferrin Saturation 30
Complement component 3 (C3) 31
Complement component 4 (C4) 32
Thyroid Stimulating Hormone (TSH)
Parathyroid Hormone (PTHi)
v25-OH Vitamin D
Table 5: Numbering of clinical variables.
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Hematology Laboratory - Variable Label
Leukocytes 49
Neutrophils 50
Lymphocytes 51
Monocytes 52
Eosinophils 53
Basophils 54
Neutrophils (Percent) 55
Lymphocytes (Percent) 56
Monocytes (Percent) 57
Eosinophils (Percent) 58
Basophils (Percent) 59
Immature Granulocyte (IG) count 60
Red blood cell 61
Hemoglobin 62
Hematocrit 63
Mean Corpuscular Volume (MCV) 64
Mean Corpuscular Hemoglobin (MCH) 65
Mean Corpuscular Hemoglobin Concentration (MCHC) 66
Erythroblasts
Erythroblasts (Percent) 67
Red blood cell Distribution Width (RDW) 68
Platelets 69
Platelet Distribution wWidth (PDW) 70
Reticulocytes (Percent)
Erythrocyte Sedimentation Rate (ESR) 71
Direct Coombs
Glucose-6-Phosphate Dehydrogenase (G6PD) quantification
Haptoglobin
Protrombrine Time
Activated Partial Thromboplastin Time (APTT)
Fibrinogen
Lupus anticoagulant
Immunology Laboratory - Variable Label
Anti-dsDNA antibodies 72
lgM Anti-cardiolipin antibodies
lgG Anti-cardiolipin antibodies
lgM AntiB2glicoprotein-I antibodies
lgG AntiB2glicoprotein-I antibodies
Table 6: Numbering of clinical variables.
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